FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, in particular to polypeptide containing variant I-OnuI of homing-endonuclease (HE), as well as to polynucleotide encoding it. A vector containing the above-mentioned polynucleotide is also disclosed. The invention also relates to a cell containing the above-mentioned polypeptide or polynucleotide, as well as to a composition containing the above-mentioned cell.
EFFECT: invention is effective for adoptive cell therapy.
16 cl, 24 dwg, 2 tbl, 14 ex
Title | Year | Author | Number |
---|---|---|---|
OPTIONS, COMPOSITIONS, AND METHODS FOR USE OF ENDONUCLEASE CBLB | 2018 |
|
RU2779097C2 |
POLYFUNCTIONAL PROTEIN MOLECULES CONTAINING DECORIN AND USE THEREOF | 2019 |
|
RU2823357C2 |
ANTI-PD-L1 AND IL-2 CYTOKINES | 2017 |
|
RU2769282C2 |
PD-L1 SPECIFIC ANTIBODIES | 2017 |
|
RU2756236C2 |
DELIVERY OF THERAPEUTIC POLYPEPTIDES VIA PSEUDOTYPED ONCOLYTIC VIRUSES | 2017 |
|
RU2758007C2 |
MULTIFUNCTIONAL FUSION PROTEINS AND THEIR USE | 2020 |
|
RU2815388C2 |
ANTI-PD-L1 ANTIBODY FOR PD-L1 DETECTION | 2018 |
|
RU2758723C2 |
FUSION PROTEIN AND ITS USE | 2020 |
|
RU2811120C2 |
PD-1 BINDING ANTIBODIES AND METHODS OF THEIR USE | 2019 |
|
RU2812280C1 |
CD73 BLOCKING ANTIBODIES | 2020 |
|
RU2819204C2 |
Authors
Dates
2022-10-05—Published
2017-09-08—Filed